Revolution Medicines Statistics

Total Valuation

RVMD has a market cap or net worth of $6.96 billion. The enterprise value is $4.81 billion.

Market Cap	6.96B
Enterprise Value	4.81B

Important Dates

The next estimated earnings date is Wednesday, May 7, 2025, after market close.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

RVMD has 185.91 million shares outstanding. The number of shares has increased by 48.24% in one year.

Current Share Class	185.91M
Shares Outstanding	185.91M
Shares Change (YoY)	+48.24%
Shares Change (QoQ)	+4.14%
Owned by Insiders (%)	2.37%
Owned by Institutions (%)	97.80%
Float	168.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.07
P/TBV Ratio	3.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.20, with a Debt / Equity ratio of 0.06.

Current Ratio	14.20
Quick Ratio	13.97
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -29.33% and return on invested capital (ROIC) is -19.97%.

Return on Equity (ROE)	-29.33%
Return on Assets (ROA)	-18.66%
Return on Invested Capital (ROIC)	-19.97%
Return on Capital Employed (ROCE)	-28.80%
Revenue Per Employee	n/a
Profits Per Employee	-$1.12M
Employee Count	534
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-753,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.10% in the last 52 weeks. The beta is 1.37, so RVMD's price volatility has been higher than the market average.

Beta (5Y)	1.37
52-Week Price Change	+3.10%
50-Day Moving Average	37.96
200-Day Moving Average	44.29
Relative Strength Index (RSI)	54.55
Average Volume (20 Days)	2,019,339

Short Selling Information

The latest short interest is 16.20 million, so 8.71% of the outstanding shares have been sold short.

Short Interest	16.20M
Short Previous Month	16.65M
Short % of Shares Out	8.71%
Short % of Float	9.63%
Short Ratio (days to cover)	12.04

Income Statement

Revenue	n/a
Gross Profit	-592.23M
Operating Income	-689.52M
Pretax Income	-522.73M
Net Income	-600.09M
EBITDA	-683.00M
EBIT	-689.52M
Earnings Per Share (EPS)	-$3.58

Full Income Statement

Balance Sheet

The company has $2.29 billion in cash and $135.84 million in debt, giving a net cash position of $2.15 billion or $11.58 per share.

Cash & Cash Equivalents	2.29B
Total Debt	135.84M
Net Cash	2.15B
Net Cash Per Share	$11.58
Equity (Book Value)	2.27B
Book Value Per Share	12.19
Working Capital	2.16B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$557.44 million and capital expenditures -$10.31 million, giving a free cash flow of -$567.74 million.

Operating Cash Flow	-557.44M
Capital Expenditures	-10.31M
Free Cash Flow	-567.74M
FCF Per Share	-$3.05

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RVMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-48.24%
Shareholder Yield	-48.24%
Earnings Yield	-8.62%
FCF Yield	-8.16%

Dividend Details

Analyst Forecast

The average price target for RVMD is $68.25, which is 81.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$68.25
Price Target Difference	81.71%
Analyst Consensus	Strong Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2